This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent. Top assignees: Shandong New Time Pharmaceutical Co., Ltd., Ampsource Biopharma Shanghai Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Shixiang Jia: Innovator in Biopharmaceuticals
Introduction
Shixiang Jia is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic proteins. With a total of 3 patents, his work focuses on addressing critical health issues such as cancer and metabolic disorders.
Latest Patents
One of Shixiang Jia's latest patents is a bispecific antibody that binds to BCMA and CD3. This invention relates to methods and uses of a bispecific antibody that specifically targets the CD3 surface antigen on immune cells and the BCMA antigen on tumor cells. The antibody is designed to bind human CD3 with high affinity, inducing T cell proliferation and mediating tumor cell killing effects. This bispecific antibody has potential applications in T cell-specific killing of target cells in in vitro tests.
Another notable patent is a dual-function protein for lipid and blood glucose regulation. This protein comprises a human GLP-1 analog and human FGF21, and it is aimed at regulating blood glucose and lipid metabolism. The invention provides a method for preparing this dual-function protein and outlines its use in creating biological substances for treating type 2 diabetes, obesity, dyslipidemia, fatty liver disease, and metabolic syndrome. The dual-function protein can synergistically regulate blood glucose and lipid levels in vivo, addressing multiple requirements for patients with type 2 diabetes.
Career Highlights
Shixiang Jia has worked with several notable companies in the biopharmaceutical sector, including Ampsource Biopharma Shanghai Inc. and Shandong New Time Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Throughout his career, Shixiang Jia has collaborated with esteemed colleagues such as Qiang Li and Zhao Dong. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking biopharmaceuticals.
Conclusion
Shixiang Jia is a distinguished inventor whose work in biopharmaceuticals has the potential to significantly impact the treatment of various health conditions. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile